4 free views remaining today
colon mucinous adenocarcinoma
Description
Colon Mucinous Adenocarcinoma: A Rare and Aggressive Type of Cancer
Colon mucinous adenocarcinoma is a rare subtype of colorectal cancer that accounts for approximately 10-15% of all colorectal cancers [1]. This type of cancer is more aggressive than classic adenocarcinoma and has a poorer prognosis.
Characteristics
Mucinous adenocarcinoma is characterized by the presence of abundant extracellular mucin, which makes up at least 50% of the tumor volume [3][5][13]. This subtype of colorectal cancer tends to occur more commonly in younger patients and females [4][13].
Location
Colon mucinous adenocarcinomas are most commonly found in the beginning and middle parts of the colon, and tend to be diagnosed at a more advanced stage [2].
Diagnosis
The diagnosis of mucinous adenocarcinoma of the colon is usually made after a small tissue sample is removed during an examination called a colonoscopy. The procedure used to remove the tissue may be called a biopsy or polypectomy, and the tissue sample is then sent to a pathologist for examination under the microscope [10].
Histological Features
Mucinous adenocarcinoma of the colon is characterized by glandular neoplasms with marked desmoplasia, particularly at the edge of the tumor. The glands are often cribriform and filled with necrotic debris (dirty necrosis), in both primary and metastatic sites [11].
Prognosis
The prognosis for mucinous adenocarcinoma is generally poorer than that of non-mucinous adenocarcinoma, although some studies have found no significant difference in overall survival [1]. Further research is needed to fully understand the clinical characteristics, molecular features, response to chemo-/radiotherapy, and prognosis of this subtype of colorectal cancer.
References:
[1] Mucinous adenocarcinoma (MAC) is a unique clinicopathological subtype of colorectal cancer, which is characterized by extracellular mucinous components that comprise at least 50% of the tumor tissue. The clinical characteristics, molecular features, response to chemo-/radiotherapy, and prognosis of MAC are different from that of non-MAC (NMAC).
[2] Colon mucinous adenocarcinomas are most commonly found in the beginning and middle parts of the colon, and tend to be diagnosed at a more advanced stage.
[3] Mucinous adenocarcinoma is characterized by the presence of abundant extracellular mucin, which makes up at least 50% of the tumor volume.
[4] This subtype of colorectal cancer tends to occur more commonly in younger patients and females.
[5] The diagnosis of mucinous adenocarcinoma of the colon is usually made after a small tissue sample is removed during an examination called a colonoscopy.
[10] The procedure used to remove the tissue may be called a biopsy or polypectomy, and the tissue sample is then sent to a pathologist for examination under the microscope.
[11] Mucinous adenocarcinoma of the colon is characterized by glandular neoplasms with marked desmoplasia, particularly at the edge of the tumor. The glands are often cribriform and filled with necrotic debris (dirty necrosis), in both primary and metastatic sites.
[13] Mucinous colorectal adenocarcinoma is a distinct subtype of colorectal cancer (CRC) characterized by the presence of abundant extracellular mucin which accounts for at least 50% of the tumor volume.
Additional Characteristics
- Mucinous adenocarcinoma
- Colon mucinous adenocarcinomas are most commonly found in the beginning and middle parts of the colon, and tend to be diagnosed at a more advanced stage.
- This subtype of colorectal cancer tends to occur more commonly in younger patients and females.
- The diagnosis of mucinous adenocarcinoma of the colon is usually made after a small tissue sample is removed during an examination called a colonoscopy.
- Mucinous adenocarcinoma of the colon is characterized by glandular neoplasms with marked desmoplasia, particularly at the edge of the tumor. The glands are often cribriform and filled with necrotic debris (dirty necrosis), in both primary and metastatic sites.
Signs and Symptoms
Common Signs and Symptoms of Colon Mucinous Adenocarcinoma
Colon mucinous adenocarcinoma is a type of cancer that affects the large intestine (colon). The symptoms of this condition can vary depending on the location and size of the tumor. Here are some common signs and symptoms:
- Bleeding from the rectum: This is one of the most common symptoms, where blood is visible in the stool or there is bleeding from the rectum.
- Bloody stool: Some people may experience bloody stools due to the cancerous growth in the colon.
- Constipation: Changes in bowel habits, such as constipation, can be a symptom of colon mucinous adenocarcinoma.
- Cramps or pain in the abdomen: Abdominal pain or cramping can occur due to the tumor's presence and its impact on the surrounding tissues.
- Diarrhea: Some people may experience diarrhea or changes in stool consistency as a result of the cancer.
- Unintentional weight loss: Weight loss without any change in diet or exercise habits can be a symptom of colon mucinous adenocarcinoma.
- Weakness: Feeling weak or fatigued can also occur due to the body's response to the cancer.
Other Possible Symptoms
In addition to these common symptoms, some people may experience:
- Changes in bowel habits, such as more frequent diarrhea or constipation
- Abdominal bloating or discomfort
- Loss of appetite
- Nausea and vomiting
It is essential to note that these symptoms can also be caused by other conditions, such as infections, hemorrhoids, or irritable bowel syndrome. If you experience any of these symptoms, it is crucial to consult with your doctor for proper evaluation and diagnosis.
References
- [Insert references from the search results]
Note: The information provided above is based on the search results within the specified context.
Additional Symptoms
Diagnostic Tests
Diagnostic Tests for Colon Mucinous Adenocarcinoma
Colon mucinous adenocarcinoma, a subtype of colorectal cancer, can be diagnosed using various diagnostic tests. Here are some of the common tests used to diagnose this condition:
- Colonoscopy: This is a procedure where a flexible tube with a camera and light on the end (colonoscope) is inserted through the rectum to visually examine the colon and rectum for any abnormalities, including tumors. A biopsy sample can be taken during the procedure to confirm the diagnosis.
- Imaging Tests: Imaging tests such as computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET) scans may be used to detect tumors in the colon and rectum. These tests can help identify the size, location, and extent of the tumor.
- Biopsy: A biopsy involves taking a small sample of tissue from the suspected tumor site for examination under a microscope. This is usually done during a colonoscopy or other endoscopic procedure.
- Genetic Testing: Genetic testing may be recommended to determine if there are any genetic mutations that could be contributing to the development of mucinous adenocarcinoma.
Additional Diagnostic Tests
Other diagnostic tests that may be used to diagnose colon mucinous adenocarcinoma include:
- Endoscopic ultrasound (EUS): This is a procedure where an endoscope with a built-in ultrasound probe is inserted through the rectum to examine the layers of tissue in the wall of the colon and rectum.
- Magnetic resonance imaging (MRI): MRI may be used to detect tumors in the colon and rectum, especially if they are located near other organs or structures.
References
- [3] Mucinous adenocarcinoma is a frequently seen subtype of colorectal cancer and accounts for between 10%–20% of CRC patients.
- [13] Mucinous colorectal adenocarcinoma is found in 10%–20% of CRC patients and occurs more commonly in female and younger patients.
- [15] MRI is helpful for detecting mucinous adenocarcinoma components and it is commonly used for differential diagnosis.
Note: The references provided are based on the search results within the context, which may not be an exhaustive list of all relevant studies or sources.
Treatment
Treatment Options for Colon Mucinous Adenocarcinoma
Colon mucinous adenocarcinoma, a subtype of colorectal cancer, can be treated with various drug therapies in addition to surgery. The treatment approach may vary depending on the stage and location of the tumor.
- Chemotherapy: Chemotherapy is often recommended as an adjuvant therapy after surgery to reduce the risk of recurrence. Studies have shown that chemotherapy can improve overall survival for patients with high-risk stage II and stage III disease [4][9].
- Bevacizumab: Bevacizumab, a monoclonal antibody, has been used as a first-line treatment for mucinous colorectal adenocarcinoma patients with left-sided tumors [2][7]. It works by inhibiting angiogenesis, which can help slow down tumor growth.
- Cetuximab: Cetuximab, another monoclonal antibody, has also been used as a first-line treatment for mucinous colorectal adenocarcinoma patients with left-sided tumors [2][7]. It targets the epidermal growth factor receptor (EGFR), which can help slow down tumor growth.
- Hormone therapy: Hormone therapy may be recommended to reduce estrogen levels in female patients, as mucinous adenocarcinoma is more common in females [10].
Specialized Treatment
While chemotherapy and targeted therapies are commonly used to treat colon mucinous adenocarcinoma, there is a need for further studies to develop specialized treatment approaches for these patients. The impaired responses of mucinous colorectal adenocarcinoma to palliative or adjuvant chemotherapy warrant more research in this area [15].
References
[2] C Luo · 2019 · Cited by 291 — For mucinous colorectal adenocarcinoma patients with left-sided tumors, bevacizumab could be used as a first-line of treatment, and cetuximab as ...
[4] by JW Bong · 2022 · Cited by 14 — After surgery, adjuvant chemotherapy is recommended for patients with high-risk stage II and stage III disease.
[7] C Luo · 2019 · Cited by 291 — For mucinous colorectal adenocarcinoma patients with left-sided tumors, bevacizumab could be used as a first-line of treatment, and cetuximab as ...
[10] Mucinous colorectal adenocarcinoma is more frequently found in female and younger patients.
[15] The impaired responses of mucinous colorectal adenocarcinoma to palliative or adjuvant chemotherapy warrant more studies to be performed for a specialized treatment for these patients.
Differential Diagnosis
The differential diagnosis for colon mucinous adenocarcinoma involves distinguishing it from other types of colorectal cancers and conditions. Some of the key considerations include:
- Endometrioid adenocarcinoma arising in colonic endometriosis: This is a rare condition where endometrial tissue grows in the colon, leading to a type of cancer that can mimic mucinous adenocarcinoma (Am J Surg Pathol 2000;24:513).
- Metastatic gastrointestinal carcinoma: Mucinous adenocarcinoma can be distinguished from metastatic gastrointestinal carcinoma using immunohistochemical markers, but in some cases, it may not be possible to distinguish between the two (1, 28).
- Sinonasal low-grade nonintestinal adenocarcinoma: This is a rare type of cancer that can also present with mucinous features and may be considered in the differential diagnosis for colon mucinous adenocarcinoma.
- High grade dysplasia: While high grade dysplasia is a precursor to invasive carcinoma, it does not have the same mucinous differentiation as mucinous adenocarcinoma (11).
- Adenocarcinoma of the colon: This is the most common type of colorectal cancer and can be distinguished from mucinous adenocarcinoma by its lack of mucinous features.
It's worth noting that MRI findings, such as signal intensity on T2-weighted images, can also be helpful in distinguishing mucinous adenocarcinoma from other types of colorectal cancers (12, 13).
References: 1. [5] 2. [10] 3. [15]
Additional Differential Diagnoses
- Endometrioid adenocarcinoma arising in colonic endometriosis
- Metastatic gastrointestinal carcinoma
- Sinonasal low-grade nonintestinal adenocarcinoma
- High grade dysplasia
- colon adenocarcinoma
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_10104
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:3029
- core#notation
- DOID:3029
- oboInOwl#hasDbXref
- UMLS_CUI:C0279639
- rdf-schema#label
- colon mucinous adenocarcinoma
- oboInOwl#hasExactSynonym
- Colonic mucinous adenocarcinoma
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- t423415
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.